Skip to content

Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest

Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01944605
Acronym
TICA
Enrollment
40
Registered
2013-09-17
Start date
2013-09-30
Completion date
2014-03-30
Last updated
2017-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Reperfusion Injury

Keywords

Endotoxin, Cytokine, Metabolism

Brief summary

Out-of-hospital cardiac arrest (CA) is a leading public health problem causing nearly one third of a million deaths annually in the US, accounting for half of all cardiovascular deaths and surpassing deaths from stroke, heart failure, and breast and lung cancer combined. Twenty to fifty percent of CA patients (pts) can be resuscitated initially but many die before hospital discharge or suffer permanent neurologic damage. Therapeutic hypothermia (TH) improves survival and neurological outcomes. Despite aggressive, targeted post arrest management, including TH, approximately 50% of pts die before leaving the hospital due to global ischemia-reperfusion injury (IRI) known as the post arrest syndrome, 1 which is a sepsis-like state characterized by elevated markers of cellular inflammation and injury. It is believed that TH works by decreasing the body's basal metabolic rate (BMR) and attenuating the systemic inflammatory response (SIR). However, specific triggers of the intense pro-inflammatory response are unclear. This gap in knowledge must be closed to identify targeted therapy to decrease IRI and improve outcomes. Blood flow to the gut is decreased markedly and intestinal tissue becomes ischemic during CA and CPR, particularly when vasoconstrictor drugs such as epinephrine, are given. IRI of the intestine increases intestinal permeability leading to intestinal microbial translocation and endotoxin release that can stimulate and perpetuate systemic inflammation and cause subsequent multi-organ dysfunction. Endotoxin also increases body temperature and energy expenditure and may attenuate TH induced reductions in BMR and hence, decrease efficacy. The purpose of this novel pilot study is to detect systemic endotoxin release following CA in humans and determine association with cytokine activation, and BMR alterations during TH.

Detailed description

Hypothesis 1 Intestinal ischemia during and following Caridac Arrest leads to increased gut permeability and endotoxin release that stimulates the Systemic Inflammatory Response that is responsible for subsequent death and disability after resuscitation. Hypothesis 2: Different degrees of systemic endotoxin activity variably affect Basic Metabolic Rate during Therapeutic Hypothermia Serial samples of blood, stool and expired gas will be measured at predetermined timepoints after ROSC from cardiac arrest.

Interventions

None listed

Sponsors

American Heart Association
CollaboratorOTHER
Virginia Commonwealth University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adult, Cardiac Arrest with ROSC receiving Therapeutic Hypothermia-

Exclusion criteria

* Age \< 18 * Cardiac Arrest of traumatic etiology * Known to be pregnant * Prisoner

Design outcomes

Primary

MeasureTime frameDescription
Detection of Endotoxin Activity48 hoursEndotoxin activity will be measured by the Endotoxin Activity Assay and values . of \>0.4 EA units will be used as the cut-off for the presence of pathological endotoxin.

Secondary

MeasureTime frameDescription
Detection of sCD1448 hoursTo demonstrate activation of endotoxin by the immune system and upstream physiologic changes necessary for systemic endotoxemia to occur
Detection of stool lactoferrin and stool α1-antitrypsin48 hoursTo demonstrate evidence of intestinal inflammation and permeability that can lead to endotoxemia and downstream cellular inflammatory responses responsible for end organ damage
Detection and quantification of inflammatory cytokines48 hoursTo demonstrate an association with the primary outcome
BMR measurement elevation48 hoursTo determine its association with endotoxemia and cytokine. BMR is being measured to determine if pts with higher levels of endotoxin and cytokines have higher BMR and therefore blunted therapeutic value of TH

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026